151 related articles for article (PubMed ID: 9694738)
1. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13.
Still IH; Cowell JK
Blood; 1998 Aug; 92(4):1456-8. PubMed ID: 9694738
[No Abstract] [Full Text] [Related]
2. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.
Reiter A; Sohal J; Kulkarni S; Chase A; Macdonald DH; Aguiar RC; Gonçalves C; Hernandez JM; Jennings BA; Goldman JM; Cross NC
Blood; 1998 Sep; 92(5):1735-42. PubMed ID: 9716603
[TBL] [Abstract][Full Text] [Related]
3. A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12).
Invernizzi R; Benatti C; Travaglino E; Girino M; Bernasconi P; Loni C; Ascari E
Haematologica; 2004 Feb; 89(2):239-41. PubMed ID: 15003903
[No Abstract] [Full Text] [Related]
4. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
[TBL] [Abstract][Full Text] [Related]
5. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
[TBL] [Abstract][Full Text] [Related]
6. A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult.
Shaaban H; Dabu J; Al-Rabi K; Gauchan D; Guron G
Ann Hematol; 2013 Jan; 92(2):285-6. PubMed ID: 22941307
[No Abstract] [Full Text] [Related]
7. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.
Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M
Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332
[TBL] [Abstract][Full Text] [Related]
8. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.
Ollendorff V; Guasch G; Isnardon D; Galindo R; Birnbaum D; Pébusque MJ
J Biol Chem; 1999 Sep; 274(38):26922-30. PubMed ID: 10480903
[TBL] [Abstract][Full Text] [Related]
9. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
[TBL] [Abstract][Full Text] [Related]
10. The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene.
Mugneret F; Chaffanet M; Maynadié M; Guasch G; Favre B; Casasnovas O; Birnbaum D; Pébusque MJ
Br J Haematol; 2000 Nov; 111(2):647-9. PubMed ID: 11122115
[TBL] [Abstract][Full Text] [Related]
11. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
Chaffanet M; Popovici C; Leroux D; Jacrot M; Adélaïde J; Dastugue N; Grégoire MJ; Hagemeijer A; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
Oncogene; 1998 Feb; 16(7):945-9. PubMed ID: 9484786
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the breakpoints in a t(8;13)(p11;q12) translocation from a patient with myeloproliferative disease using fluorescence in situ hybridization.
Chernova O; Still I; Kalaycio M; Hoeltge G; Cowell JK
Genes Chromosomes Cancer; 1998 Feb; 21(2):160-5. PubMed ID: 9491328
[TBL] [Abstract][Full Text] [Related]
13. ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteins.
Kunapuli P; Somerville R; Still IH; Cowell JK
Oncogene; 2003 May; 22(22):3417-23. PubMed ID: 12776193
[TBL] [Abstract][Full Text] [Related]
14. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
[TBL] [Abstract][Full Text] [Related]
15. Identification of four new translocations involving FGFR1 in myeloid disorders.
Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].
Zhou F; Chen S; Chao H; Zhang R; Zhou M; Pan J
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):291-6. PubMed ID: 25916288
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).
Popovici C; Adélaïde J; Ollendorff V; Chaffanet M; Guasch G; Jacrot M; Leroux D; Birnbaum D; Pébusque MJ
Proc Natl Acad Sci U S A; 1998 May; 95(10):5712-7. PubMed ID: 9576949
[TBL] [Abstract][Full Text] [Related]
18. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).
Guasch G; Popovici C; Mugneret F; Chaffanet M; Pontarotti P; Birnbaum D; Pébusque MJ
Blood; 2003 Jan; 101(1):286-8. PubMed ID: 12393597
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a t(8;13)(p11;q11-12) in an atypical myeloproliferative disorder.
Smedley D; Somers G; Venter D; Chow CW; Cooper C; Shipley J
Genes Chromosomes Cancer; 1998 Jan; 21(1):70-3. PubMed ID: 9443043
[TBL] [Abstract][Full Text] [Related]
20. The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.
Kulkarni S; Reiter A; Smedley D; Goldman JM; Cross NC
Genomics; 1999 Jan; 55(1):118-21. PubMed ID: 9889006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
